Not available
Quote | Israel Chemicals Limited (NYSE:ICL)
Last: | $4.27 |
---|---|
Change Percent: | -0.24% |
Open: | $4.2 |
Close: | $4.27 |
High: | $4.29 |
Low: | $4.19 |
Volume: | 295,390 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Israel Chemicals Limited (NYSE:ICL)
2024-05-09 13:28:02 ET ICL Group Ltd (ICL) Q1 2024 Earnings Conference Call May 09, 2024, 08:30 AM ET Company Participants Peggy Reilly Tharp - VP-Global IR Raviv Zoller - CEO Aviram Lahav - CFO Conference Call Participants Ben Theurer - Barclays ...
2024-05-09 11:23:30 ET More on ICL Group ICL Group Ltd 2023 Q4 - Results - Earnings Call Presentation ICL Group Ltd (ICL) Q4 2023 Earnings Call Transcript ICL Group Q1 2024 Earnings Preview ICL accelerates biologicals portfolio growth in Brazil with Nitro 100...
Message Board Posts | Israel Chemicals Limited (NYSE:ICL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $ICL News Article - ICL Reports Record First Quarter 2022 Results and Raises Guidance | whytestocks | investorshangout | 05/11/2022 2:40:59 PM |
whytestocks: $ICL News Article - 7 Fertilizer Stocks to Buy for April | whytestocks | investorshangout | 04/13/2022 6:45:55 PM |
whytestocks: $ICL News Article - Is Olin a Good Growth Stock to Buy Now? | whytestocks | investorshangout | 03/07/2022 8:50:52 PM |
whytestocks: $ICL News Article - Watch for Continued Gains in Shares of ICL Group Ltd. (ICL) | whytestocks | investorshangout | 10/25/2021 7:35:53 PM |
whytestocks: $ICL News Article - Shares of ICL Group Ltd. (ICL) Rise Above Previous 52-Week High | whytestocks | investorshangout | 09/29/2021 4:00:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Israel Chemicals Limited Company Name:
ICL Stock Symbol:
NYSE Market:
Israel Chemicals Limited Website:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Delivers solid sequential quarterly improvement in sales of $1.7 billion and adjusted EBITDA of $362 million ICL (NYSE: ICL) (TASE: ICL) , a leading global specialty minerals company, today reported its financial results for the first quarter ended March 31, 2024. Consolidat...
ICL ( NYSE: ICL) (TASE: ICL ) , a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation and technology officer of ICL, will be presenting at 2024 BMO Global Farm to Market Conference at 11 a.m. ET on Thursday, May 16, 2024....